Login

How A/B Dynamics Transformed Its Workspace: A Conversation with CEO Tim Rogers 00:10:00

Share On Facebook Share On Twitter

Interview with Tim Rogers CEO

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
BVZ Group Half-Year Financials 2019: An Interview with Fernando Lehner, Company Leader | Fernando Lehner - CEO of bvz holding ag
00:10:00
Ciena CEO Gary Smith discusses the acquisition of Cyan.
00:10:00
1stDibs: Leading Marketplace for Extraordinary Design with Tim Whidden at NFT.NYC | David Rosenblatt, CEO, 1stdibs.Com IncDIBS:NMQ
00:10:00
Financial Considerations After Spousal Loss | DANIEL STOUS - SHAREHOLDER & LEAD WEALTH ADVISOR of Flagstone Financial Management
00:10:00
Forecasting Market Trends for the Latter Half of 2023 | William Davies, CIO , Columbia Threadneedle Investments.
00:10:00
Exploring the Long-Term Growth Potential of Diverse Royalty Assets | Brian Dalton , CEO, Altius Minerals Corp.
00:10:00
The Value of Professional Financial Advice | Ken Robinson, Owner, Practical Financial Planning.
00:10:00
NioBay Metals Project in Northern Ontario
00:10:00
OUR TRACK RECORD is Success driven by people and partnerships|Glenn R. August, Chief Executive Officer,Oak Hill Partners LLC
00:10:00
Demonstrating Advisor Value: Navigating the Challenges of Client Value Propositions|Tim Buckley,CEO,Vanguard
00:10:00
Daniel Priestley on Building a Brand and Sales Model: From Rolex to Small Business Strategies
00:10:00
Mastering Emotional Investing: Insights from Allodium Investment Consultants | David J. Bromelkamp - CEO of Allodium Investment Consultants

© 2026 Nehu